Ningxia Zhongke Biotechnology Co., Ltd. / Fundamentals
Income statement
- Net revenue
€53.23M - Cost of goods sold
€66.34M - Gross profit
-€13.11M - SG&A expenses
€2.79M - R&D expenses
€1.46M - EBITDA
-€29.81M - D&A
-€557.38K - EBIT
-€29.96M - Interest expenses
€9.27M - EBT
-€39.08M - Tax expenses
-€296.87K - Net income
-€33.90M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€24.84M - Changes in working capital
€0.00 - Operating cash flow
-€31.34M - Capex
€4.66M - Other investing cash flow
€3.11K - Net investing cash flow
-€4.65M - Total cash dividends paid
-€377.64K - Issuance of common stock
€0.00 - Debt repayment
€29.31M - Other financing cash flow
€15.20M - Net financing cash flow
€44.13M - Foreign exchange effects
€14.10K - Net change in cash
€8.18M - Cash at end of period
€9.11M - Free cash flow
-€26.68M
Balance sheet
- Cash and cash equivalents
€9.12M - Cash and short-term investments
€9.12M - Total receivables
€13.13M - Inventory
€19.33M - Other current assets
€6.28M - Total current assets
€47.86M - Property, plant & equipment
€209.49M - Goodwill
€0.00 - Intangible assets
€7.81M - Long-term investments
€0.00 - Other non-current assets
€10.15M - Total non-current assets
€228.01M - Total assets
€275.87M - Accounts payable
€98.14M - Short-term debt
€26.88M - Other current liabilities
€110.87M - Total current liabilities
€237.47M - Long-term debt
€29.90M - Deferred tax liabilities
€274.24K - Other non-current liabilities
€79.74K - Total non-current liabilities
€32.38M - Total liabilities
€269.85M - Common stock
€81.49M - Retained earnings
-€211.00M - Other equity
€0.00 - Total equity
€6.02M - Total liabilities and shareholders' equity
€275.87M
Company information
- Market capitalization
€381.37M - Employees
834 - Enterprise Value
€3.48B
Company ratios
- Gross margin
-
-24.6% Much worse than peer group: 26.4% - EBITDA margin
-
-56.0% Much worse than peer group: 17.2% - EBIT margin
-
-56.3% Much worse than peer group: 10.0% - EBT margin
-
-73.4% Much worse than peer group: 11.0% - Net margin
-
-63.7% Much worse than peer group: 8.9% - ROE
-
-563.2% Much worse than peer group: 7.7% - ROA
-
-12.3% Worse than peer group: 5.3% - Asset turnover
-
19.3% Much worse than peer group: 56.3% - FCF margin
-
-67.6% Much worse than peer group: -7.1% - FCF yield
-9.4% - Efficiency ratio
156.0% - Net sales per employee
-
€63.83K - Net income per employee
-
-€40.65K